Tinea corporis in human immunodeficiency virus-positive patients: Case report and assessment of oral therapy

International Journal of Dermatology

Volumn 42, Issue 10, 2003, Pages 839-843

  Burkhart, Craig N ^a,b   Chang, Howard ^a,b   Gottwald, Lorie ^a,b  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; EPITHEAR; FLUCONAZOLE; FLUOCINONIDE; GRISEOFULVIN; INDINAVIR; ITRACONAZOLE; KETOCONAZOLE; LOPINAVIR PLUS RITONAVIR; MEVINIC ACID DERIVATIVE; MEVINOLIN; NELFINAVIR; NEVIRAPINE; NISOLDIPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; SIMVASTATIN; TERBINAFINE; UNCLASSIFIED DRUG; ZARIT; ZIDOVUDINE;

ADULT; ANAMNESIS; ANEMIA; CASE REPORT; CONFERENCE PAPER; DATA ANALYSIS; DERMATOMYCOSIS; DERMATOPHYTE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG ERUPTION; DRUG FATALITY; DRUG METABOLISM; DRUG POTENCY; DRUG POTENTIATION; DRUG TOXICITY; FUNGUS CULTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; LIVER DISEASE; MALE; MEDLINE; NEUTROPENIA; PATIENT CARE; PRURITUS; RISK ASSESSMENT; SKIN DISEASE; TINEA CORPORIS; VIRUS LOAD; VIRUS RESISTANCE;

ADMINISTRATION, ORAL; ADULT; ANTIFUNGAL AGENTS; HIV INFECTIONS; HUMANS; MALE; NAPHTHALENES; TINEA;

EID: 0142248910     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2003.01894.x     Document Type: Conference Paper

References (21)

1. r extracellular proteinase from Trichophyton rubrum. Mycoses 1994; 37: 85-92.
2. Dahl MV. Dermatophytosis and the immune response. J Am Acad Dermatol 1994; 31: S34-S41.
3. Ali AS, Falconer A, Ifram M, et al. Expression of the peptide antibiotics human B defensin-1 and human B defensin-2 in normal human skin. J Invest Dermatol 2001; 117: 106-111.
4. Frohm M, Agerbath B, Ahangari G, et al. The expression of the gene encoding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 1997; 272: 15,258-15,263.
5. Wingens M, Van Bergen BH, Hienestra PS. Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes. J Invest Dermatol 1998; III: 996-1002.
6. Wagner DK, Sohnle PG. Cutaneous defenses against dermatophytes and yeasts. Clin Microbiol Rev 1995; 8: 317-355.
7. McGregor JM, Hay RJ. An immunoinhibitory cell wall glycoprotein (mannan) from Trichophyton rubrum. J Invest Dermatol 1991; 97: 955-956.
8. Hay RJ, Moore M. Mycology. In: Champion RH, Burton JL, Burns DA, Breathnach SM, eds. Textbook of Dermatology, 6th edn. London: Blackwell Science, 2001.
9. Chastain MA, Reed RJ, Pankey GA. Deep dermatophytosis: Report of two cases and review of the literature. Cutis 2001; 67: 457-462.
10. Tsang P, Hopkins T, Jimenez-Lucho V. Deep dermatophytosis caused by Trichophyton rubrum in a patient with AIDS. J Am Acad Dermatol 1996; 34: 1090-1091.
11. Johnson RA. An update on dermatophytosis: Dermatophyte infections in human immune deficiency virus (HIV) disease. J Am Acad Dermatol 2000; 43: S135-S142.
12. Elewski BE, Sullivan J. Dermatophytes as opportunistic pathogens. J Am Acad Dermatol 1994; 30: 1021-1022.
13. Kaatz WA, Wollina U. Fluconazole-resistant life-threatening deep trichophytia: Successful treatment with itraconazole. Eur J Dermatol 1997; 7: 497-498.
14. Chen AWJ, Kuo JWL, Chen JS, et al. Dermatophyte pseudomycetoma: A case report. Br J Dermatol 1993; 129: 729-732.
15. Hironaga M, Okazaki N, Saito K, et al. Trichophyton mentagrophytes granulomas: Unique systemic dissemination to lymph nodes, testes, vertebrae, and brain. Arch Dermatol 1983; 119: 482-490.
16. Boughene-Stambouli O, Merad-Boudia A. Antifungal therapeutics in the dermatophytic disease (chronic granulomatous dermatophytosis): Failure of griseofulvin, itraconazole, ketoconazole, and terbinafine. J Mycol Med 1996; 6: 139-141.
17. Myskowski PL, White MH, Ahkami R. Fungal disease in the immunocompromised host. Dermatol Clin 1997; 15: 1-14.
18. Drugs for HIV infection. Med Letter 2001; 43: 119-125.
19. Stockley IH. Drug Interactions. London: Pharmaceutical Press, 1999: 146-208.
20. Moossavi M, Bagheri B, Scher RK. Systemic dermatologic therapy: Systemic antifungal therapy. Dermatol Clin 2001; 19: 1-29.
21. Shear NH, Gupta AK. Terbinafine for the treatment of pedal onychomycosis: A foot closer to the promised land of cured nails? Arch Dermatol 1995; 131: 937-942.